- Home
- ACRV vs WGRX Comparison
ACRV vs WGRX Comparison
Compare ACRV & WGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- WGRX
- Stock Information
- Founded
- ACRV 2018
- WGRX 2022
- Country
- ACRV United States
- WGRX United States
- Employees
- ACRV 61
- WGRX N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- WGRX Other Pharmaceuticals
- Sector
- ACRV Health Care
- WGRX Health Care
- Exchange
- ACRV Nasdaq
- WGRX Nasdaq
- Market Cap
- ACRV 73.5M
- WGRX 140.2M
- IPO Year
- ACRV 2022
- WGRX 2025
- Fundamental
- Price
- ACRV $2.24
- WGRX $3.82
- Analyst Decision
- ACRV Strong Buy
- WGRX
- Analyst Count
- ACRV 6
- WGRX 0
- Target Price
- ACRV $21.80
- WGRX N/A
- AVG Volume (30 Days)
- ACRV 162.1K
- WGRX 183.4K
- Earning Date
- ACRV 05-13-2025
- WGRX 01-01-0001
- Dividend Yield
- ACRV N/A
- WGRX N/A
- EPS Growth
- ACRV N/A
- WGRX N/A
- EPS
- ACRV N/A
- WGRX N/A
- Revenue
- ACRV N/A
- WGRX $18,128,831.00
- Revenue This Year
- ACRV N/A
- WGRX N/A
- Revenue Next Year
- ACRV N/A
- WGRX N/A
- P/E Ratio
- ACRV N/A
- WGRX N/A
- Revenue Growth
- ACRV N/A
- WGRX N/A
- 52 Week Low
- ACRV $2.14
- WGRX $2.32
- 52 Week High
- ACRV $11.90
- WGRX $5.69
- Technical
- Relative Strength Index (RSI)
- ACRV 22.41
- WGRX N/A
- Support Level
- ACRV $5.00
- WGRX N/A
- Resistance Level
- ACRV $5.65
- WGRX N/A
- Average True Range (ATR)
- ACRV 0.44
- WGRX 0.00
- MACD
- ACRV -0.33
- WGRX 0.00
- Stochastic Oscillator
- ACRV 2.85
- WGRX 0.00
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About WGRX Wellgistics Health Inc. Common Stock
Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. Its solutions provide a seamless prescription ecosystem through an integrated technology platform, wholesale distribution, and fulfillment network focused on Independent Pharmacies and Specialty Lite medications.